Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglass Wu

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|November 17, 2007
Glycolipids as immunostimulating agentsDouglass Wu, Masakazu Fujio, Chi-Huey Wong
Journal of Molecular Biology|September 8, 2009
Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligandsAndré Schiefner, Masakazu Fujio, Douglass Wu, et al.
Journal of the American Chemical Society|July 13, 2006
Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activityMasakazu Fujio, Douglass Wu, Raquel Garcia-Navarro, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramidesGuo-Wen Xing, Douglass Wu, Michael A Poles, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvantXiangming Li, Masakazu Fujio, Masakazu Imamura, et al.
The Journal of Experimental Medicine|November 30, 2005
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunityDirk M Zajonc, Igor Maricic, Douglass Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1dDouglass Wu, Dirk M Zajonc, Masakazu Fujio, et al.
Journal of the American Chemical Society|August 21, 2008
Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine productionPi-Hui Liang, Masakazu Imamura, Xiangming Li, et al.
Journal of the American Chemical Society|April 15, 2004
Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosidesLac V Lee, Kristen E Bower, Fu-Sen Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2007
Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipidsYa-Jen Chang, Jing-Rong Huang, Yi-Chien Tsai, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|November 17, 2007
Glycolipids as immunostimulating agentsDouglass Wu, Masakazu Fujio, Chi-Huey Wong
Journal of Molecular Biology|September 8, 2009
Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligandsAndré Schiefner, Masakazu Fujio, Douglass Wu, et al.
Journal of the American Chemical Society|July 13, 2006
Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activityMasakazu Fujio, Douglass Wu, Raquel Garcia-Navarro, et al.
Bioorganic & Medicinal Chemistry|March 23, 2005
Synthesis and human NKT cell stimulating properties of 3-O-sulfo-alpha/beta-galactosylceramidesGuo-Wen Xing, Douglass Wu, Michael A Poles, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvantXiangming Li, Masakazu Fujio, Masakazu Imamura, et al.
The Journal of Experimental Medicine|November 30, 2005
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunityDirk M Zajonc, Igor Maricic, Douglass Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1dDouglass Wu, Dirk M Zajonc, Masakazu Fujio, et al.
Journal of the American Chemical Society|August 21, 2008
Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine productionPi-Hui Liang, Masakazu Imamura, Xiangming Li, et al.
Journal of the American Chemical Society|April 15, 2004
Inhibition of the proteolytic activity of anthrax lethal factor by aminoglycosidesLac V Lee, Kristen E Bower, Fu-Sen Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2007
Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipidsYa-Jen Chang, Jing-Rong Huang, Yi-Chien Tsai, et al.
Pageof 2